Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan and Dapagliflozin in HFmrEF and HFpEF with CpcPH
NCT07147114Phase 4Recruiting
- Sponsor
- Gachon University Gil Medical Center
- Start
- Nov 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of macitentan in heart failure (HF), pulmonary hypertension (PH), sponsored by Gachon University Gil Medical Center. Started Nov 2025; status: recruiting.
02
Drugs
macitentan
03
Conditions
heart failure (HF)pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT07147114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07147114.